Skip to ContentSkip to Navigation
breed in kennis  -  sterk in techniek
Over ons Praktische zaken Waar vindt u ons dr. J.C. Oosterwijk

Speerpunten

klinische genetica

familaire / erfelijke tumoren

erfelijke borst / eierstokkanker

Publicaties

Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study

Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

Occurrence of Malignancies Other than Breast and Ovarian Cancer in Female Carriers of a BRCA1/2 Germline Pathogenic Variant

Validation of the BOADICEA model in a prospective cohort of BRCA1/2 pathogenic variant carriers.

PRDM10 directs FLCN expression in a novel disorder overlapping with Birt-Hogg-Dubé syndrome and familial lipomatosis

Breast cancer risks associated with missense variants in breast cancer susceptibility genes

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women

Genetic control of tumor development in malformation syndromes

Genotype-phenotype correlations for pancreatic cancer risk in Dutch melanoma families with pathogenic CDKN2A variants

Pers/media

Wat als de kans op kanker levensgroot is? 'Ik ga niet zitten wachten tot ik ziek word'

Erfelijke kanker in de familie

Laten testen of je erfelijk belast bent?

Sustainable Development Goals

SDG 3 – Goede gezondheid en welzijnSDG 5 – GendergelijkheidSDG 16 – Vrede, rechtvaardigheid en sterke instellingen

Meer informatie over de Sustainable Development Goals.